{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:06:12Z","timestamp":1785229572219,"version":"3.55.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Praziquantel is the only drug available for the treatment of schistosomiasis and the state of the exhausted drug discovery pipeline is alarming. We restarted investigations on the abandoned antischistosomal Ro 13-3978, an aryl hydantoin discovered in the early 1980s by Hoffmann La-Roche.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Newly transformed schistosomula and adult Schistosoma mansoni were studied in the presence of Ro 13-3978 in vitro. The metabolic stability of Ro 13-3978 was determined in vitro using human and mouse liver S9 fractions. Dose\u2013response relationship, stage specificity, hepatic shift and scanning electron microscopy studies were carried out in S. mansoni-infected mice. In addition, efficacy experiments were conducted in rodents infected with Echinostoma caproni and Fasciola hepatica as well as in S. mansoni-infected immunocompromised nude (Foxn1nu) mice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Ro 13-3978 showed minor in vitro activity and no damage to the tegument was found. No cytotoxicity was detected for Ro 13-3978. Ro 13-3978 was metabolically stable. ED50 values of 138.9 and 14.6 mg\/kg were calculated for the treatment of juvenile and adult S. mansoni infections, respectively, with a single oral dose of Ro 13-3978. SEM studies revealed severe damage to the worms 48 h post-treatment of infected mice. A single oral dose of Ro 13-3978 (100 mg\/kg) administered to S. mansoni-infected (Foxn1nu) mice reduced the worm burden by 88%. Ro 13-3978 was not active against E. caproni and F. hepatica in vivo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Ro 13-3978 has excellent antischistosomal properties in vivo. Structure\u2013activity relationship studies with the aryl hydantoins have been launched in order to elucidate active pharmacophores, further investigate the mechanism of action and to identify a derivative with minimal antiandrogenic effects.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkv016","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T05:05:38Z","timestamp":1424235938000},"page":"1788-1797","source":"Crossref","is-referenced-by-count":19,"title":["Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal"],"prefix":"10.1093","volume":"70","author":[{"given":"Jennifer","family":"Keiser","sequence":"first","affiliation":[{"name":"1 \u00a0Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland"},{"name":"2 \u00a0University of Basel, CH-4003 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Panic","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland"},{"name":"2 \u00a0University of Basel, CH-4003 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Vargas","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland"},{"name":"2 \u00a0University of Basel, CH-4003 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunkai","family":"Wang","sequence":"additional","affiliation":[{"name":"3 \u00a0College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Dong","sequence":"additional","affiliation":[{"name":"3 \u00a0College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagsen","family":"Gautam","sequence":"additional","affiliation":[{"name":"3 \u00a0College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Vennerstrom","sequence":"additional","affiliation":[{"name":"3 \u00a0College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,16]]},"reference":[{"key":"2022020123412924600_DKV016C1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.idc.2012.03.004","article-title":"Schistosomiasis","volume":"26","author":"Gryseels","year":"2012","journal-title":"Infect Dis Clin N Am"},{"key":"2022020123412924600_DKV016C2","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"key":"2022020123412924600_DKV016C3","doi-asserted-by":"crossref","first-page":"e2106","DOI":"10.1371\/journal.pntd.0002106","article-title":"Evaluation of the health-related quality of life of children in Schistosoma haematobium-endemic communities in Kenya: a cross-sectional study","volume":"7","author":"Terer","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2022020123412924600_DKV016C4","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"2022020123412924600_DKV016C5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1586\/14787210.2013.844066","article-title":"Diagnosis and treatment of schistosomiasis in children in the era of intensified control","volume":"11","author":"Knopp","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2022020123412924600_DKV016C6","first-page":"3531","article-title":"Antimalarials in the treatment of schistosomiasis","volume":"18","author":"Keiser","year":"2012","journal-title":"Curr Pharm Des"},{"key":"2022020123412924600_DKV016C7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/1389557511313040003","article-title":"The evolution of drugs on schistosoma treatment: looking to the past to improve the future","volume":"13","author":"da Rocha Pitta","year":"2013","journal-title":"Mini Rev Med Chem"},{"key":"2022020123412924600_DKV016C8","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1093\/jac\/dkq233","article-title":"Activity of antiandrogens against juvenile and adult Schistosoma mansoni in mice","volume":"65","author":"Keiser","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2022020123412924600_DKV016C9","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4269\/ajtmh.14-0029","article-title":"Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13\u20133978","volume":"90","author":"Wang","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"2022020123412924600_DKV016C10","first-page":"261","article-title":"3-Arylhydantoine, eine substanzklasse mit schistosomizider wirkung","volume":"19","author":"Link","year":"1984","journal-title":"Eur J Med Chem"},{"key":"2022020123412924600_DKV016C11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S0031182009991739","article-title":"In vitro and in vivo trematode models for chemotherapeutic studies","volume":"137","author":"Keiser","year":"2010","journal-title":"Parasitology"},{"key":"2022020123412924600_DKV016C12","article-title":"Antiandrogenic and schistosomicidal imidazolidine derivatives","author":"Bernauer"},{"key":"2022020123412924600_DKV016C13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S0031182009990965","article-title":"Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni","volume":"137","author":"Manneck","year":"2010","journal-title":"Parasitology"},{"key":"2022020123412924600_DKV016C14","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1128\/AAC.06177-11","article-title":"Antischistosomal activities of mefloquine-related arylmethanols","volume":"56","author":"Ingram","year":"2012","journal-title":"Antimicrobial Agents Chemother"},{"key":"2022020123412924600_DKV016C15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cbic.200390016","article-title":"Synthesis and biological evaluation of pyrazolylnaphthoquinones as new potential antiprotozoal and cytotoxic agents","volume":"4","author":"Sperandeo","year":"2003","journal-title":"Chembiochem"},{"key":"2022020123412924600_DKV016C16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/bmc.2880","article-title":"Pharmacokinetics, protein binding and metabolism of a quinoxaline urea analog as an NF-\u03baB inhibitor in mice and rats by LC-MS\/MS","volume":"27","author":"Gautam","year":"2013","journal-title":"Biomed Chromatogr"},{"key":"2022020123412924600_DKV016C17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2133\/dmpk.DMPK-10-RG-041","article-title":"Metabolite profiling of praziquantel and its analogs during the analysis of in vitro metabolic stability using information-dependent acquisition on a hybrid triple quadrupole linear ion trap mass spectrometer","volume":"25","author":"Huang","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"2022020123412924600_DKV016C18","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1128\/AAC.01537-06","article-title":"The in vitro and in vivo activities of synthetic trioxolanes on major human schistosome species","volume":"51","author":"Xiao","year":"2007","journal-title":"Antimicrobial Agents Chemother"},{"key":"2022020123412924600_DKV016C19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S2214-109X(13)70078-0","article-title":"The drug and vaccine landscape for neglected diseases (2000\u201311): a systematic assessment","volume":"1","author":"Pedrique","year":"2013","journal-title":"Lancet Global Health"},{"key":"2022020123412924600_DKV016C20","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/jac\/dkr178","article-title":"Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro","volume":"66","author":"Keiser","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2022020123412924600_DKV016C21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-3024.1986.tb00866.x","article-title":"Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo","volume":"8","author":"Pearce","year":"1986","journal-title":"Parasite Immunol"},{"key":"2022020123412924600_DKV016C22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0014-4894(85)90041-4","article-title":"Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice","volume":"60","author":"Sabah","year":"1985","journal-title":"Exp Parasitol"},{"key":"2022020123412924600_DKV016C23","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1128\/AAC.02741-14","article-title":"Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni","volume":"58","author":"Meister","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020123412924600_DKV016C24","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1128\/AAC.01129-13","article-title":"Disposition of mefloquine and enpiroline is highly influenced by a chronic Schistosoma mansoni infection","volume":"57","author":"Ingram","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/70\/6\/1788\/42358588\/jac_70_6_1788.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/70\/6\/1788\/42358588\/jac_70_6_1788.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T23:43:32Z","timestamp":1643759012000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/70\/6\/1788\/728592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,16]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,2,16]]},"published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkv016","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,6]]},"published":{"date-parts":[[2015,2,16]]}}}